According to the Centers for Disease Control and Prevention, ADHD affects between four and 12 % of all school-aged kids in the usa, making it probably the most common childhood disorders. Between 66 and 85 % of the young children maintain the diagnosis into adolescence and adulthood. Yet, both the rate of which children are diagnosed with ADHD, and even the existence of the disorder itself, have proven controversial, with many critics alleging that doctors are actually too quick to slap children with the label. The implications of the controversy are significant: treatment of kids with ADHD runs between $36 billion and $52 billion per year in the usa.Galapagos is permitted receive up to $360 million altogether additional obligations for undisclosed developmental and regulatory milestones, along with milestone payments for minimum annual net product sales thresholds, and additional double-digit royalty obligations on net sales. Our programs in CF show guarantee, Galapagos CEO Onno van de Stolpe said in a declaration. Partnering with AbbVie allows us to crank up our commitment significantly, share development knowledge and risk, and increase our chances of bringing best-in-course therapies to CF patients. Related StoriesMedUni Vienna researchers discover genetic cause of a uncommon diseaseACR releases 2015 Guideline for Treatment of Rheumatoid ArthritisDiscovery could offer clues to how some infections control expression of genetic materialGalapagos released its CF analysis in 2005 with the Cystic Fibrosis Foundation, which resulted in 19 novel disease-modifying targets validated in the standard preclinical model for the disease.